Medications

Harms reporting in trials of orlistat

The reporting of trials of orlistat in the 1990s appears to have understated harms, both in the summarized results submitted to the European Medicines Agency for drug approval, and in the published papers, according to a ...

Aug 16, 2016
popularity0 comments 0